Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | EVP Chief People & Culture Off | September 28, 2026 | September 30, 2026 |
| Sonendo, Inc.SONX · Entity 9738 | Director | June 16, 2023 | June 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date September 28, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 123,478 |
Reported balance
After 2026-09-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-28 · Sale · Disposed 2,565 · Balance 123,478 F1: On May 28, 2026, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2: Included in this number are 71,903 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 28, 2026, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Included in this number are 71,903 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027.
Sonendo, Inc.
Report date June 16, 2023 · Filed June 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 59,998 |
Reported balance
After 2023-06-16 transaction · row 1
1 source rowRow 1 · 2023-06-16 · Grant · Acquired 25,316 · Balance 59,998 F1: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in full on the earlier to occur of: (i) the one year anniversary of the Grant Date (ii) and the date of the 2024 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board through the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.08 · Expires 2033-06-15 | Direct | 32,520 |
Reported balance
After 2023-06-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-16 · Grant · Acquired 32,520 · Balance 32,520 F2: The Options vest in full on the earlier to occur of: (i) the one year anniversary of the Grant Date and (ii) the date of the 2024 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in full on the earlier to occur of: (i) the one year anniversary of the Grant Date (ii) and the date of the 2024 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board through the applicable vesting date.
F2: The Options vest in full on the earlier to occur of: (i) the one year anniversary of the Grant Date and (ii) the date of the 2024 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board through the applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
3D SYSTEMS CORP
Report date September 03, 2020 · Filed September 08, 2020
Section 16 reporting ended · disclosed 2020-09-08. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 5,297 | $0.00 | $5.30 |
DisclosureSEC source: 0001093557-22-000056 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,758 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 16,880 unvested restricted stock units, 5,297 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,756 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:39 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 1,671 | $0.00 | $1.67 |
DisclosureSEC source: 0001093557-21-000287 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,461 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/2 shall vest 24 months from the Grant Date, 1/8 shall vest 27 months from the Grant Date, 1/8 shall vest 30 months from the grant date, 1/8 shall vest 33 months from the Grant Date, and the remaining balance shall vest 36 months from the Grant Date. Share units represent a contingent right to receive one share of DexCom Inc. Common Stock. F2 · balance_after: Included in this number are 13,461 unvested restricted stock units, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| November 23, 2021 Filed Nov 23, 2021 23:57 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,195 | $612.26 | $731,650.70 |
DisclosureSEC source: 0001093557-21-000264 · edgardoc.xml · nonDerivative · entry 2 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,790 F3 · shares: On August 3, 2021, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 11,790 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 23:57 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 856 | $638.65 | $546,684.40 |
DisclosureSEC source: 0001093557-21-000264 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,985 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 11,790 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 00:29 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 5,634 | $0.00 | $5.63 |
DisclosureSEC source: 0001093557-21-000057 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,841 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 13,841 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 8,207 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| November 19, 2020 Filed Nov 21, 2020 01:22 UTC Amendment | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 8,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-20-000313 · wf-form4a_160592173395043.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,207 F1 · security: This amendment to Form 4 corrects the number of restricted stock units ("RSUs") granted and the date of grant as previously reported on Form 4 filed November 10, 2020. The correct date of grant for the RSUs is November 19, 2020 and the correct number of RSUs granted is 8,207. F2 · shares: Represents a grant of RSUs that vest in four annual installments on November 19, 2021, November 19, 2022, November 19, 2023 and November 19, 2024. Share units represent a contingent right to receive one share of Dexcom, Inc. common stock upon settlement for no consideration. F2 · balance_after: Represents a grant of RSUs that vest in four annual installments on November 19, 2021, November 19, 2022, November 19, 2023 and November 19, 2024. Share units represent a contingent right to receive one share of Dexcom, Inc. common stock upon settlement for no consideration. Read SEC document |
| November 08, 2020 Filed Nov 10, 2020 21:30 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 7,707 | $0.00 | $7.71 |
DisclosureSEC source: 0001093557-20-000302 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,707 F1 · shares: Represents a grant of restricted stock units that vests in four annual installments on November 08, 2021, November 8, 2022, November 8, 2023 and November 8, 2024. Share units represent a contingent right to receive one share of Dexcom, Inc. common stock. F2 · balance_after: Included in this number are 7,707 unvested restricted stock units, 7,707 of which were granted on November 8, 2020 and shall vest through November 8, 2024. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 22:48 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | Tax withholdingCommon Stock | 1,972 | $5.81 | $11,457.32 |
DisclosureSEC source: 0001209191-20-047307 · doc4.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, People and Culture 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,378 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on December 4, 2017. Read SEC document |
| June 15, 2020 Filed Jun 23, 2020 01:12 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | Tax withholdingCommon Stock | 702 | $7.58 | $5,321.16 |
DisclosureSEC source: 0001209191-20-038336 · doc4.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, People and Culture 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,350 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on June 13, 2019. Read SEC document |
| March 04, 2020 Filed Mar 4, 2020 22:53 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | SaleCommon Stock | 3,178 | $9.58 | $30,444.92 |
DisclosureSEC source: 0001209191-20-016298 · doc4.xml · nonDerivative · entry 3 Stern Sadie · CIK 0001797971 · EVP, People and Culture 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,052 F3 · shares: The transaction reported was the sale of the 3,178 shares awarded to the Reporting Person on March 2, 2020. The Reporting Person will remit $10,200.43 of the proceeds of such sale to the Issuer to satisfy tax withholding with respect to this award. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.52 to $9.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 4 of this Form 4. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 22:53 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 3,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016298 · doc4.xml · nonDerivative · entry 2 Stern Sadie · CIK 0001797971 · EVP, People and Culture 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,230 F2 · shares: On March 2, 2020, the Reporting Person was awarded 3,178 shares of restricted stock under the Issuer's 2015 Incentive Plan in satisfaction of amounts earned under the 2019 Executive Bonus Plan and, as such, all shares awarded were immediately vested. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 22:53 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | Tax withholdingCommon Stock | 887 | $9.53 | $8,453.11 |
DisclosureSEC source: 0001209191-20-016298 · doc4.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, People and Culture 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,052 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock units originally made on March 1, 2019. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:14 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 19,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011196 · doc4.xml · nonDerivative · entry 2 Stern Sadie · CIK 0001797971 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,939 F2 · shares: The Reporting Person has been awarded 19,773 shares of restricted stock under the Issuer's 2015 Incentive Plan. One-third of the total shares awarded vest on February 15, 2021, an additional one-third of the total shares awarded vest on February 15, 2022, and the remaining shares awarded vest on February 15, 2023. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:14 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | Tax withholdingCommon Stock | 2,488 | $12.13 | $30,179.44 |
DisclosureSEC source: 0001209191-20-011196 · doc4.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,166 F1 · shares: Shares reported were withheld to satisfy tax withholding obligations with respect to the vesting of a grant of restricted stock originally made on February 15, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.